Bleakley Financial Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.46M | Sell |
31,582
-56,406
| -64% | -$2.61M | 0.04% | 328 |
|
|
2025
Q1 | $5.37M | Buy |
87,988
+1,948
| +2% | +$119K | 0.17% | 117 |
|
|
2024
Q4 | $4.87M | Buy |
86,040
+49,616
| +136% | +$2.81M | 0.15% | 120 |
|
|
2024
Q3 | $1.88M | Sell |
36,424
-1,502
| -4% | -$77.7K | 0.06% | 264 |
|
|
2024
Q2 | $1.58M | Sell |
37,926
-25,392
| -40% | -$1.05M | 0.05% | 313 |
|
|
2024
Q1 | $3.43M | Buy |
63,318
+7,994
| +14% | +$434K | 0.1% | 194 |
|
|
2023
Q4 | $2.84M | Sell |
55,324
-5,315
| -9% | -$273K | 0.09% | 210 |
|
|
2023
Q3 | $3.52M | Sell |
60,639
-13,170
| -18% | -$764K | 0.12% | 155 |
|
|
2023
Q2 | $4.72M | Buy |
73,809
+8,274
| +13% | +$529K | 0.15% | 129 |
|
|
2023
Q1 | $4.54M | Buy |
65,535
+9,310
| +17% | +$645K | 0.15% | 122 |
|
|
2022
Q4 | $4.05M | Buy |
+56,225
| New | +$4.05M | 0.14% | 134 |
|